262 related articles for article (PubMed ID: 2394609)
1. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa.
Van der Schueren E; Van den Bogaert W; Vanuytsel L; Van Limbergen E
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):301-11. PubMed ID: 2394609
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
3. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
Van den Bogaert W; van der Schueren E; Horiot JC; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1649-55. PubMed ID: 7153077
[TBL] [Abstract][Full Text] [Related]
4. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.
Bentzen SM; Ruifrok AC; Thames HD
Radiother Oncol; 1996 Feb; 38(2):89-101. PubMed ID: 8966232
[TBL] [Abstract][Full Text] [Related]
5. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
Bartelink H; Van den Bogaert W; Horiot JC; Jager J; van Glabbeke M
Eur J Cancer; 2002 Mar; 38(5):667-73. PubMed ID: 11916549
[TBL] [Abstract][Full Text] [Related]
6. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?
Denham JW; Peters LJ; Johansen J; Poulsen M; Lamb DS; Hindley A; O'Brien PC; Spry NA; Penniment M; Krawitz H; Williamson S; Bear J; Tripcony L
Radiother Oncol; 1999 Aug; 52(2):157-64. PubMed ID: 10577701
[TBL] [Abstract][Full Text] [Related]
7. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.
Fowler JF; Harari PM; Leborgne F; Leborgne JH
Radiother Oncol; 2003 Nov; 69(2):161-8. PubMed ID: 14643953
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
[TBL] [Abstract][Full Text] [Related]
9. Solid tumor models for the assessment of different treatment modalities: XXV. Comparison of the effect of one radiation fraction per day with multiple fractions per day (MFD) given either continuously or intermittently on tumor response and normal tissue reaction.
Looney WB; Hopkins HA
Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):203-10. PubMed ID: 3949571
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy.
Narayan S; Lehmann J; Coleman MA; Vaughan A; Yang CC; Enepekides D; Farwell G; Purdy JA; Laredo G; Nolan K; Pearson FS; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):756-62. PubMed ID: 18417299
[TBL] [Abstract][Full Text] [Related]
11. The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects.
Van den Bogaert W; van der Schueren E; Horiot JC; De Vilhena M; Schraub S; Svoboda V; Arcangeli G; de Pauw M; Van Glabbeke M
Radiother Oncol; 1995 May; 35(2):91-9. PubMed ID: 7569030
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
13. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Acute Radiation Mucositis using an Oral Mucosal Dose Surface Model in Carbon Ion Radiotherapy for Head and Neck Tumors.
Musha A; Shimada H; Shirai K; Saitoh J; Yokoo S; Chikamatsu K; Ohno T; Nakano T
PLoS One; 2015; 10(10):e0141734. PubMed ID: 26512725
[TBL] [Abstract][Full Text] [Related]
15. Accelerated versus conventional fractionation. The degree of incomplete repair in human skin with a four-hour-fraction interval studied after postmastectomy irradiation.
Turesson I; Notter G
Acta Oncol; 1988; 27(2):169-79. PubMed ID: 3390347
[TBL] [Abstract][Full Text] [Related]
16. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up.
Turesson I; Thames HD
Radiother Oncol; 1989 Jun; 15(2):169-88. PubMed ID: 2762590
[TBL] [Abstract][Full Text] [Related]
17. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II study of high-dose rate interstitial radiotherapy for head and neck cancer.
Teshima T; Inoue T; Ikeda H; Murayama S; Furukawa S; Shimizutani K
Strahlenther Onkol; 1992 Nov; 168(11):617-21. PubMed ID: 1455289
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of acute oral mucositis by keratinocyte growth factor: fractionated irradiation.
Dörr W; Spekl K; Farrell CL
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):245-51. PubMed ID: 12182998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]